-
-
-
-
-
-
-
Ligand Pharma (LGND) PT Raised to $162 at Oppenheimer
-
-
-
-
-
-
-
Ligand Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
Ligand Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Ligand Pharma (LGND) Provides Update on Portfolio Progress and Recent Transactions; Introduces 2024 Guidance
-
-
-
-
-
-
-
Ligand Acquires Royalty on Sanofi’s TZIELD® for $20 Million
-
-
-
-
-
-
-
Ligand Reports Second Quarter 2023 Financial Results
-
-
-
-
-
-
-
Ligand Distribution of OmniAb Complete and Business Combination Closed
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

